Income Statement
IMMUNOME INC.
IMNM
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Revenue
|
6.94 | 9.04 | 14.02 | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - | - |
|
Gross Profit
|
6.94 | 9.04 | 14.02 | - | - | - |
|
Operating Expenses
|
231.05 | 314.84 | 123.55 | 36.90 | 25.20 | 12.26 |
|
Research & Development
|
177.29 | 129.54 | 23.09 | 23.27 | 14.11 | 7.49 |
|
Selling, General & Administrative
|
43.77 | 32.96 | 19.66 | 13.63 | 11.09 | 4.78 |
|
Other Operating Expenses
|
- | - | - | - | - | - |
|
Operating Income
|
-224.11 | -305.80 | -109.53 | -36.90 | -25.20 | -12.26 |
|
Non-Operating Income
|
- | - | - | - | - | - |
|
Interest Income
|
- | - | - | - | - | 0.00 |
|
Interest Expense
|
- | - | - | - | - | 0.02 |
|
Other Non-Op Income / Expense
|
- | - | - | 0.01 | 0.49 | - |
|
Income Before Tax
|
- | - | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - |
|
Net Income
|
-212.39 | -292.96 | -106.81 | -36.90 | -24.71 | -17.84 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - |
|
EBITDA
|
-221.61 | -304.20 | -109.03 | -36.48 | -24.40 | -11.46 |
|
Earnings Per Share (Basic)
|
-2.43 | -5.00 | -5.38 | -3.09 | -2.14 | - |
|
Diluted EPS
|
-2.43 | -5.00 | -5.38 | -3.09 | -2.14 | - |
|
Weighted Average Shares
|
87.35 | 58.64 | 19.84 | 12.13 | 11.54 | - |
|
Diluted Weighted Avg Shares
|
87.35 | 58.64 | 19.84 | 12.13 | 11.54 | - |
|
Comprehensive Income
|
-212.45 | -292.93 | -106.78 | - | - | - |